市場調查報告書
商品編碼
1472014
腦監測市場規模 - 按產品類型、方式、程序、應用、最終用途 - 全球預測,2024 年 - 2032 年Brain Monitoring Market Size - By Product Type, Modality, Procedure, Application, End-use - Global Forecast, 2024 - 2032 |
由於癲癇、阿茲海默症和帕金森氏症等神經系統疾病的盛行率不斷增加,預計 2024 年至 2032 年,大腦監測市場規模的複合年成長率將達到 6.4%。根據世界神經病學聯合會的數據,全世界約有 40% 的人口患有某種神經系統疾病,預計到 2050 年將增加一倍。
最近,醫療保健專業人員和患者對神經系統疾病早期介入重要性的認知顯著提高。此外,腦部監測設備(例如腦電圖(EEG)、功能性磁振造影(fMRI)和腦磁圖(MEG))的技術進步提高了準確性、靈敏度和可訪問性,正在推動產品的採用。
容易患神經系統疾病的老年人口不斷增加,以及醫療保健支出的增加,促使政府採取措施促進大腦健康。臨床環境之外不斷擴大的技術應用,包括運動表現監測、認知增強和腦機介面開發,正在提供新的成長機會。此外,醫療保健組織、學術機構和技術公司之間的策略合作和夥伴關係將提高市場滲透率。
腦監測產業分為產品類型、模式、程序類型、應用、最終用途和區域。
根據應用,失智症領域的市場規模預計在 2024 年至 2032 年期間將以 6.9% 的速度成長。全球範圍內失智症盛行率不斷上升,特別是在老齡化人口中,這一點受到了支持。失智症相關認知障礙的複雜性需要全面、持續的監測,以最佳化患者照護和管理。此外,對失智症診斷和治療研發的日益重視正在促進大腦監測技術的創新,從而開發出更靈敏、更準確和更易於使用的監測解決方案。
根據模式,穿戴式裝置領域的大腦監測市場到 2032 年將以 6.9% 的複合年成長率成長,因為它們具有攜帶性,允許在傳統臨床環境之外持續監測大腦活動。這種可訪問性可以實現即時資料收集和分析,以促進神經系統疾病的早期檢測。此外,穿戴式科技的進步,例如小型化、增強的感測器功能和無線連接,有助於提高設備的舒適度、準確性和可用性,推動醫療保健專業人員和消費者的採用。
由於人口老化,歐洲腦監測產業預計在 2024 年至 2032 年期間將以 6.1% 的速度成長。該地區強大的醫療基礎設施、領先的研究機構和支持性政府措施正在促進臨床和研究環境中的創新和產品採用。此外,對個人化醫療和精準醫療保健的日益重視正在推動針對個別患者需求的創新腦監測解決方案的開發,進一步刺激區域市場的成長。
Brain monitoring market size is anticipated to observe 6.4% CAGR from 2024 to 2032, driven by the increasing prevalence of neurological disorders, such as epilepsy, Alzheimer's disease, and Parkinson's disease. As per World Federation of Neurology, around 40% of the population worldwide suffer from some kind of neurological condition and is anticipated to double by 2050.
Lately, the awareness among healthcare professionals and patients regarding the importance of early intervention in neurological conditions is significantly rising. Moreover, technological advancements in brain monitoring devices, such as electroencephalography (EEG), functional magnetic resonance imaging (fMRI), and magnetoencephalography (MEG) to enhance accuracy, sensitivity, and accessibility is driving the product adoption.
The growing aging population prone to neurological disorders and an increase in healthcare expenditure are leading to government initiatives to promote brain health. The expanding technological applications beyond clinical settings, including sports performance monitoring, cognitive enhancement, and brain-computer interface development, are offering new growth opportunities. Moreover, strategic collaborations and partnerships between healthcare organizations, academic institutions, and technology companies will enhance the market penetration.
The brain monitoring industry is divided into product type, modality, type of procedure, application, end use and region.
By application, the market size from the dementia segment is slated to witness 6.9% growth rate during 2024-2032. This is favored by the rising prevalence of dementia worldwide, particularly among the aging population. The complexity of dementia-related cognitive impairments is necessitating comprehensive and continuous monitoring to optimize patient care and management. Furthermore, the growing emphasis on R&D in dementia diagnosis and treatment is fostering innovations in brain monitoring technologies, leading to the development of more sensitive, accurate, and accessible monitoring solutions.
Based on modality, the brain monitoring market from the wearable segment will grow at 6.9% CAGR through 2032, owing to their portability, allowing continuous monitoring of brain activity outside traditional clinical settings. This accessibility enables real-time data collection and analysis for facilitating early detection of neurological disorders. Moreover, advancements in wearable technology, such as miniaturization, enhanced sensor capabilities, and wireless connectivity, helps improve device comfort, accuracy, and usability, driving adoption among both healthcare professionals and consumers.
Europe brain monitoring industry is expected to expand at 6.1% rate over 2024-2032, attributed to the aging population. The presence of robust healthcare infrastructure, leading research institutions, and supportive government initiatives in the region is fostering innovation and product adoption across clinical and research settings. Furthermore, the growing emphasis on personalized medicine and precision healthcare is driving the development of innovative brain monitoring solutions tailored to individual patient needs, further stimulating the regional market growth.